Rongda Xu

1.8k total citations
31 papers, 1.3k citations indexed

About

Rongda Xu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Spectroscopy. According to data from OpenAlex, Rongda Xu has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 9 papers in Spectroscopy. Recurrent topics in Rongda Xu's work include Analytical Chemistry and Chromatography (8 papers), Insect and Pesticide Research (5 papers) and Neurobiology and Insect Physiology Research (5 papers). Rongda Xu is often cited by papers focused on Analytical Chemistry and Chromatography (8 papers), Insect and Pesticide Research (5 papers) and Neurobiology and Insect Physiology Research (5 papers). Rongda Xu collaborates with scholars based in United States, Japan and China. Rongda Xu's co-authors include Daniel B. Kassel, Karl J. Kramer, Theodore L. Hopkins, Zhiyuan Zhang, R.J. Skene, Stephen L. Gwaltney, Michael B. Wallace, Lihong Shi, Marc Navre and Jeffrey A. Stafford and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Rongda Xu

29 papers receiving 1.3k citations

Peers

Rongda Xu
Rongda Xu
Citations per year, relative to Rongda Xu Rongda Xu (= 1×) peers Hideshi Inoue

Countries citing papers authored by Rongda Xu

Since Specialization
Citations

This map shows the geographic impact of Rongda Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongda Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongda Xu more than expected).

Fields of papers citing papers by Rongda Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongda Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongda Xu. The network helps show where Rongda Xu may publish in the future.

Co-authorship network of co-authors of Rongda Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Rongda Xu. A scholar is included among the top collaborators of Rongda Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongda Xu. Rongda Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Min Hee, Alexander I. Spira, Ki Hyeong Lee, et al.. (2023). 1333P A global phase 1b study of ORIC-114, a highly selective, brain penetrant EGFR and HER2 inhibitor, in patients with advanced solid tumors harboring EGFR Exon 20 or HER2 alterations. Annals of Oncology. 34. S769–S769. 5 indexed citations
2.
Tolcher, Anthony W., Shivaani Kummar, Manish R. Patel, et al.. (2021). Initial results from a phase 1b study of ORIC-101, a glucocorticoid receptor antagonist, in combination with nab-paclitaxel in patients with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 2553–2553. 1 indexed citations
3.
Xu, Tong, Xiaoqi Li, Mengmeng Huang, et al.. (2020). A Preferable Approach for the Quality Control of Xiaoer Chiqiao Qingre Granules Based on the Combination of Chromatographic Fingerprints and Chemometrics. Journal of Analytical Methods in Chemistry. 2020. 1–9. 4 indexed citations
4.
Xu, Xiao, Wanhong Xu, Wei Tang, et al.. (2016). AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients. Molecular Cancer Therapeutics. 15(11). 2586–2597. 69 indexed citations
5.
Zhang, Yinong, et al.. (2013). Preparative two-dimensional liquid chromatography/mass spectrometry for the purification of complex pharmaceutical samples. Journal of Chromatography A. 1324. 86–95. 34 indexed citations
7.
Zeng, Lu, Rongda Xu, Yinong Zhang, & Daniel B. Kassel. (2011). Two-dimensional supercritical fluid chromatography/mass spectrometry for the enantiomeric analysis and purification of pharmaceutical samples. Journal of Chromatography A. 1218(20). 3080–3088. 29 indexed citations
8.
Xu, Rongda, et al.. (2010). A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry. Journal of Chromatography A. 1217(10). 1616–1625. 24 indexed citations
9.
Zeng, Lu, et al.. (2008). Parallel SFC/MS‐MUX screening to assess enantiomeric purity. Chirality. 20(8). 885–895. 10 indexed citations
10.
Wallace, Michael B., Jun Feng, Zhiyuan Zhang, et al.. (2008). Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(7). 2362–2367. 50 indexed citations
11.
Zeng, Lu, et al.. (2007). Parallel supercritical fluid chromatography/mass spectrometry system for high-throughput enantioselective optimization and separation. Journal of Chromatography A. 1169(1-2). 193–204. 26 indexed citations
12.
Feng, Jun, Zhiyuan Zhang, Michael B. Wallace, et al.. (2007). Discovery of Alogliptin:  A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV. Journal of Medicinal Chemistry. 50(10). 2297–2300. 326 indexed citations
13.
Xu, Rongda, Bi‐Ching Sang, Marc Navre, & Daniel B. Kassel. (2006). Cell‐based assay for screening 11 β ‐hydroxysteroid dehydrogenase inhibitors using liquid chromatography/tandem mass spectrometry detection. Rapid Communications in Mass Spectrometry. 20(11). 1643–1647. 9 indexed citations
14.
Jenkins, Kelly M., et al.. (2004). Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries. Journal of Pharmaceutical and Biomedical Analysis. 34(5). 989–1004. 57 indexed citations
15.
Xu, Rongda, et al.. (2002). High-Throughput Mass-Directed Parallel Purification Incorporating a Multiplexed Single Quadrupole Mass Spectrometer. Analytical Chemistry. 74(13). 3055–3062. 27 indexed citations
16.
Kerwin, James L., František Tureček, Rongda Xu, et al.. (1999). Mass Spectrometric Analysis of Catechol–Histidine Adducts from Insect Cuticle. Analytical Biochemistry. 268(2). 229–237. 53 indexed citations
17.
Huang, Xin, Rongda Xu, M. Dale Hawley, Theodore L. Hopkins, & Karl J. Kramer. (1998). Electrochemical Oxidation ofN-Acyldopamines and Regioselective Reactions of Their Quinones withN-Acetylcysteine and Thiourea. Archives of Biochemistry and Biophysics. 352(1). 19–30. 25 indexed citations
18.
Xu, Rongda, et al.. (1998). Benzoquinone levels as a function of age and gender of the red flour beetle, Tribolium castaneum. Insect Biochemistry and Molecular Biology. 28(12). 969–977. 46 indexed citations
19.
Xu, Rongda, et al.. (1997). Catecholamine and histidyl protein cross-linked structures in sclerotized insect cuticle. Insect Biochemistry and Molecular Biology. 27(2). 101–108. 51 indexed citations
20.
Xu, Rongda, Xin Huang, Thomas D. Morgan, et al.. (1996). Characterization of Products from the Reactions ofN-Acetyldopamine Quinone withN-Acetylhistidine. Archives of Biochemistry and Biophysics. 329(1). 56–64. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026